ZNTL — Zentalis Pharmaceuticals
Median target
$9
calls from the last 12 months
Implied return
+192.2%
median target vs. price
Coverage
9 analysts · 10 calls
updated in the last 12 months
Consensus
7/2/0+7 net
Buy / Hold / Sell
Which analysts are behind ZNTL's consensus?
See every current rating, price target and the analysts' track records for Zentalis Pharmaceuticals — plus the full analyst rankings, firm analytics and screener.
The consensus above reflects 9 analysts with calls on ZNTL updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.
ZNTL elsewhere on AnalystEdge
The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.
Trending today: not in any of today's trending tables (Gaining attention, Losing attention, Most followed)
| Date | Source | Who | Action | Detail | Amount |
|---|---|---|---|---|---|
| 2026-08-14 | Insiders | Walters Group +210% owner | Insider purchase | 4.3M sh @ $3.50 | $15.2M |
More: insider activity · executive branch · trending